How many institutions held TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in Q1 2015?

84 institutional investors reported TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value for Q1 2015. Use the holders table for investor-level position and value details.

Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

Q: What does CUSIP G8807B106 represent in this 13F holders report?

CUSIP G8807B106 is the security identifier for TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value used to aggregate holder disclosures.

CUSIP: G8807B106

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class: Equity / Ordinary Share $0.00001 Par Value
Shares outstanding: 51,428,000
Total 13F shares: 20,888,616
Share change: +363,800
Total reported value: $362,467,742
Price per share: $17.35
Number of holders: 84
Value change: +$7,467,773
Number of buys: 37
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2015
Previous quarter: Q4 2014

Recent filing periods for CUSIP G8807B106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAUPOST GROUP LLC/MA	13F	Company	12%	6,061,228	$90,434,000	—	31 Dec 2014	13F
VANGUARD GROUP INC	13F	Company	2.9%	1,486,025	$22,172,000	—	31 Dec 2014	13F
FIRST MANHATTAN CO. LLC.	13F	Company	2.8%	1,446,960	$21,588,000	—	31 Dec 2014	13F
BlackRock Fund Advisors	13F	Company	2.3%	1,200,149	$17,906,000	—	31 Dec 2014	13F
OppenheimerFunds, Inc.	13F	Company	2.1%	1,086,175	$16,206,000	—	31 Dec 2014	13F
STATE STREET CORP	13F	Company	1.9%	960,160	$14,322,000	—	31 Dec 2014	13F
Foundation Asset Management, LP	13F	Company	1.8%	933,881	$13,934,000	—	31 Dec 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.4%	727,526	$10,855,000	—	31 Dec 2014	13F
D. E. Shaw & Co., Inc.	13F	Company	1.2%	640,639	$9,558,000	—	31 Dec 2014	13F
ROYCE & ASSOCIATES LP	13F	Company	1.1%	574,400	$8,570,000	—	31 Dec 2014	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.67%	342,948	$5,117,000	—	31 Dec 2014	13F
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD	13F	Company	0.58%	296,234	$4,420,000	—	31 Dec 2014	13F
Rock Springs Capital Management LP	13F	Company	0.56%	290,000	$4,327,000	—	31 Dec 2014	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.56%	288,852	$4,309,000	—	31 Dec 2014	13F
DEUTSCHE BANK AG\	13F	Company	0.54%	278,209	$4,148,000	—	31 Dec 2014	13F
Clearline Capital LP	13F	Company	0.49%	250,550	$3,738,000	—	31 Dec 2014	13F
NORTHERN TRUST CORP	13F	Company	0.48%	247,842	$3,698,000	—	31 Dec 2014	13F
NORGES BANK	13F	Company	0.48%	245,617	$3,665,000	—	31 Dec 2014	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.45%	233,812	$3,488,000	—	31 Dec 2014	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.44%	227,543	$3,395,000	—	31 Dec 2014	13F
MORGAN STANLEY	13F	Company	0.34%	175,702	$2,621,000	—	31 Dec 2014	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.33%	172,016	$2,617,000	—	31 Dec 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.29%	148,349	$2,213,000	—	31 Dec 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.26%	135,087	$2,015,000	—	31 Dec 2014	13F
State of New Jersey Common Pension Fund D	13F	Company	0.24%	125,459	$1,872,000	—	31 Dec 2014	13F
Bank of New York Mellon Corp	13F	Company	0.23%	116,508	$1,739,000	—	31 Dec 2014	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.19%	96,069	$1,726,000	—	31 Dec 2014	13F
CREDIT SUISSE AG/	13F	Company	0.22%	112,964	$1,685,000	—	31 Dec 2014	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.19%	99,170	$1,480,000	—	31 Dec 2014	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.19%	98,210	$1,466,000	—	31 Dec 2014	13F
HighVista Strategies LLC	13F	Company	0.17%	86,700	$1,294,000	—	31 Dec 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.16%	83,931	$1,252,000	—	31 Dec 2014	13F
MACQUARIE GROUP LTD	13F	Company	0.15%	77,548	$1,157,000	—	31 Dec 2014	13F
REINHART PARTNERS, LLC.	13F	Company	0.14%	71,850	$1,072,000	—	31 Dec 2014	13F
BlackRock Investment Management, LLC	13F	Company	0.13%	68,488	$1,022,000	—	31 Dec 2014	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.12%	63,879	$954,000	—	31 Dec 2014	13F
Absolute Return Capital, LLC	13F	Company	0.12%	62,921	$939,000	—	31 Dec 2014	13F
A.R.T. Advisors, LLC	13F	Company	0.12%	59,885	$893,000	—	31 Dec 2014	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.11%	57,773	$862,000	—	31 Dec 2014	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	48,092	$717,000	—	31 Dec 2014	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.09%	46,775	$698,000	—	31 Dec 2014	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	44,531	$664,000	—	31 Dec 2014	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.08%	43,666	$651,000	—	31 Dec 2014	13F
Roundview Capital LLC	13F	Company	0.08%	41,917	$625,000	—	31 Dec 2014	13F
TEACHERS ADVISORS, LLC	13F	Company	0.06%	32,920	$491,000	—	31 Dec 2014	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.06%	29,105	$434,000	—	31 Dec 2014	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.06%	28,808	$430,000	—	31 Dec 2014	13F
ProShare Advisors LLC	13F	Company	0.05%	26,395	$394,000	—	31 Dec 2014	13F
Swiss National Bank	13F	Company	0.05%	26,142	$390,000	—	31 Dec 2014	13F
Numeric Investors LLC	13F	Company	0.05%	25,805	$385,000	—	31 Dec 2014	13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q1 2015

As of 31 Mar 2015, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,888,616 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, BlackRock Fund Advisors, FIRST MANHATTAN CO, OPPENHEIMER FUNDS INC, STATE STREET CORP, NORGES BANK, BlackRock Institutional Trust Company, N.A., Foundation Asset Management, LP, and ARMISTICE CAPITAL, LLC. This page lists 84 institutional shareholders reporting positions in this security for the Q1 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders

Q1 2015 holders

Holder diff

-2

Investor	Q4 2014 Shares	Q1 2015 Shares	Share Diff	Share Chg %	Q4 2014 Value $	Q1 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.